Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine
Crossref DOI link: https://doi.org/10.1007/s40256-016-0175-2
Published Online: 2016-06-02
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bertrand, Michel E.
Vlachopoulos, Charalambos
Mourad, Jean-Jacques
License valid from 2016-06-02